OTCMKTS:VTRLY Vitrolife AB (publ) (VTRLY) Stock Price, News & Analysis $16.25 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$16.25▼$16.2550-Day Range$13.20▼$16.2552-Week Range$16.25▼$16.25VolumeN/AAverage Volume100 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartDividendHeadlinesStock AnalysisAnalyst ForecastsChartDividendHeadlines Get Vitrolife AB (publ) alerts: Email Address Ad Weiss RatingsThe next companies to potentially benefit thanks to Nvidia are …Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.Click here to learn more. About Vitrolife AB (publ) Stock (OTCMKTS:VTRLY)Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was founded in 1994 and is based in Gothenburg, Sweden.Read More VTRLY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VTRLY Stock News HeadlinesOctober 27, 2023 | finance.yahoo.comVitrolife AB (publ) - Interim report Q3, 2023: Profitable growth globally despite headwind in the U.S.October 18, 2023 | wsj.comVitrolife ABJuly 26, 2024 | Weiss Ratings (Ad)The next companies to potentially benefit thanks to Nvidia are …Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.October 5, 2023 | finance.yahoo.comElection committee for Vitrolife AB (publ)October 4, 2023 | finance.yahoo.comVitrolife Group Annual and Sustainability Report 2022October 4, 2023 | finance.yahoo.comVitrolife: Conference call interim reportOctober 4, 2023 | finance.yahoo.comVitrolife AB: Interim report Q1, 2023: Good start to the yearOctober 4, 2023 | finance.yahoo.comReport from Annual General Meeting of Vitrolife AB (publ)July 26, 2024 | Weiss Ratings (Ad)The next companies to potentially benefit thanks to Nvidia are …Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.October 4, 2023 | finance.yahoo.comConference call interim report: Vitrolife AB (publ)October 4, 2023 | finance.yahoo.comInterim report Q2, 2023: Strong growth in APAC - Vitrolife AB (publ)October 4, 2023 | finance.yahoo.comVitrolife AB (publ) announces changes in the Board of DirectorsOctober 4, 2023 | finance.yahoo.comMaria Forss, SVP Consumables business area, to leave the Vitrolife GroupOctober 4, 2023 | finance.yahoo.comCEO has purchased shares in Vitrolife ABSee More Headlines Receive VTRLY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vitrolife AB (publ) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 5/17 Dividend4/26/2024Dividend Payable5/17/2024Today7/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:VTRLY CUSIPN/A CIKN/A Webwww.vitrolife.com Phone46-3-17-21-80-00FaxN/AEmployees1,132Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMs. Bronwyn Brophy O´Connor (Age 50)CEO & President Comp: $7.44MMr. Patrik Tolf (Age 54)Chief Financial Officer Mr. Claus Bisgaard (Age 47)Senior Vice President of Technologies Guillermo Ferrando (Age 33)Vice President Strategy & Corporate development Olivia Natens (Age 54)Senior Vice President of Sales & Marketing Frank Pettersson (Age 57)Acting Senior Vice President of HR & Sustainability Mr. Rickard Ericsson (Age 53)Senior Vice President of Consumables Ricardo Capella (Age 56)Senior Vice President Genetic Services More ExecutivesKey CompetitorsAinosNASDAQ:AIMDWBICO Group AB (publ)OTCMKTS:CLLKFBone BiologicsNASDAQ:BBLGWCaliber Imaging & DiagnosticsOTCMKTS:LCDXCell MedXOTCMKTS:CMXCView All Competitors VTRLY Stock Analysis - Frequently Asked Questions How have VTRLY shares performed this year? Vitrolife AB (publ)'s stock was trading at $13.30 at the beginning of 2024. Since then, VTRLY shares have increased by 22.2% and is now trading at $16.25. View the best growth stocks for 2024 here. How do I buy shares of Vitrolife AB (publ)? Shares of VTRLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:VTRLY) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vitrolife AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Vitrolife AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.